AstraZeneca lupus drug produces positive results in trial
LONDON, Nov 17 (Reuters) - An experimental lupus drug from AstraZeneca significantly improved the symptoms of lupus in a mid-stage clinical trial, boosting prospects for a medicine the company believes could become a major seller. Only one new drug -- GlaxoSmithKline's Benlysta -- has been
Read more